PME30046
Human FGF-4 (136AA) Protein
Größe
£368.00
- SKU:
- PME30046
- Zusätzliche Namen:
- Fibroblast growth factor 4;FGF-4;Heparin secretory-transforming protein 1;HST;HST-1;HSTF-1;Heparin-binding growth factor 4;HBGF-4;Transforming protein KS3;FGF4;HST;HSTF1;KS3
- Molekulargewicht:
- 15.1 KDa
- Reinheit:
- Greater than 95% as determined by reducing SDS-PAGE.
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Hersteller:
- DIMA Biotechnology Ltd
- Formulierung:
- Lyophilized from a 0.2 μm filtered solution of PBS; 5% Trehalose; pH 7.4.
- Target:
- FGF-4
- Not available:
- Not available
- Weitere Details:
- Fibroblast growth factor 4(FGF-4) is a heparin binding member of the FGF family. The human FGF4 cDNA encodes 206 amino acids (aa) with a 33 aa signal sequence and a 173 aa mature protein with an FGF homology domain that contains a heparin binding region near the C-terminus. Mature human FGF4 shares 91%; 82%; 94% and 91% aa identity with mouse; rat; canine and bovine FGF4; respectively. Human FGF-4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors; FGF R1c; 2c; 3c and 4; is spatially and temporally regulated during embryonic development. FGF-4 is proposed to play a physiologically relevant role in human embryonic stem cell selfrenewal. It promotes stem cell proliferation; but may also aid differentiation depending on context and concentration; and is often included in embryonic stem cell media in vitro. FGF-4 is mitogenic for fibroblasts and endothelial cells in vitro and has autocrine transforming potential. It is a potent angiogenesis promoter in vivo and has been investigated as therapy for coronary artery disease.
- Versandbedingungen:
- Ambient